{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:49:00Z","timestamp":1792244940007,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Adelaide University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Non-functioning pituitary adenomas (NFPA) are one of the most frequent pituitary adenoma subtypes, yet dedicated management guidelines do not exist. This study aimed to characterise real-world clinical decision-making across the spectrum of NFPA presentations and to identify areas of practice conformity versus heterogeneity within and between specialty groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional, anonymous electronic survey was administered to endocrinologists, neurosurgeons, ENT surgeons, and radiation oncologists involved in pituitary adenoma care in Australia and New Zealand between January and April 2025. Three clinical scenarios were presented: an incidental microadenoma, an incidental asymptomatic macroadenoma, and a symptomatic macroadenoma with visual compromise. Concordance was defined as greater than 70% agreement on a single response within any group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 145 clinicians completed the survey (99 endocrinologists, 31 surgeons, 15 radiation oncologists). Areas of conformity included broad anterior pituitary hormonal evaluation, conservative management of incidental asymptomatic macroadenomas, and active intervention for symptomatic disease with visual loss. Significant heterogeneity was identified in ophthalmological assessment, repeat imaging intervals, post-operative MRI and visual field timing, and multidisciplinary team (MDT) meeting referral rates. Compared to general endocrinologists, pituitary subspecialty endocrinologists were significantly more likely to refer patients for MDT discussion and know the caseload of the surgeon to whom they were referring, and less likely to measure serum cortisol immediately post-operatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This survey identifies clinically important variation in NFPA management, concentrated in domains lacking guideline recommendations. These findings highlight the need for dedicated NFPA guidelines spanning the full spectrum of NFPA presentations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-026-01716-3","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:57:22Z","timestamp":1783072642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinician decision-making in non-functioning pituitary adenomas: an Australian and New Zealand interdisciplinary survey study"],"prefix":"10.1007","volume":"29","author":[{"given":"Edward","family":"Mignone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Saran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkis","family":"Psaltis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Jukes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gorayski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Torpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-6482","authenticated-orcid":false,"given":"Sunita MC","family":"De Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"1","key":"1716_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2014.11.004","volume":"44","author":"S Melmed","year":"2015","unstructured":"Melmed S (2015) Pituitary tumors. Endocrinol Metab Clin North Am 44(1):1\u20139","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"1716_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","volume":"21","author":"G Ntali","year":"2018","unstructured":"Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21(2):111\u2013118","journal-title":"Pituitary"},{"issue":"5","key":"1716_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.beem.2009.05.005","volume":"23","author":"Y Greenman","year":"2009","unstructured":"Greenman Y, Stern N (2009) Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23(5):625\u2013638","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"1716_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eprac.2022.10.004","volume":"29","author":"E Giraldi","year":"2023","unstructured":"Giraldi E, Allen JW, Ioachimescu AG (2023) Pituitary Incidentalomas: Best Practices and Looking Ahead. Endocr Pract 29(1):60\u201368","journal-title":"Endocr Pract"},{"issue":"12","key":"1716_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"1716_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19(12):722\u2013740","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1716_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1716_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322","journal-title":"Pituitary"},{"issue":"11","key":"1716_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41574-025-01148-2","volume":"21","author":"S Melmed","year":"2025","unstructured":"Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M et al (2025) Consensus on acromegaly therapeutic outcomes: an update. Nat Rev Endocrinol 21(11):718\u2013737","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"1716_CR10","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1716_CR11","doi-asserted-by":"publisher","first-page":"E541","DOI":"10.1227\/NEU.0000000000001392","volume":"79","author":"M Ziu","year":"2016","unstructured":"Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM et al (2016) Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas. Neurosurgery 79(4):E541\u2013E543","journal-title":"Neurosurgery"},{"issue":"10","key":"1716_CR12","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1210\/jc.2008-0643","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Pereira AM, Romijn JA (2008) Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93(10):3717\u20133726","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1716_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41574-025-01134-8","volume":"21","author":"M Fleseriu","year":"2025","unstructured":"Fleseriu M, Gurnell M, McCormack A, Fukuoka H, Glezer A, Langlois F et al (2025) Pituitary incidentaloma: a Pituitary Society international consensus guideline statement. Nat Rev Endocrinol 21(10):638\u2013655","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"1716_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1530\/EC-18-0065","volume":"7","author":"NM Vaninetti","year":"2018","unstructured":"Vaninetti NM, Clarke DB, Zwicker DA, Yip CE, Tugwell B, Doucette S et al (2018) A comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses. Endocr Connect 7(5):768\u2013776","journal-title":"Endocr Connect"},{"issue":"7\u20138","key":"1716_CR15","first-page":"595","volume":"110","author":"AS Tresoldi","year":"2020","unstructured":"Tresoldi AS, Carosi G, Betella N, Del Sindaco G, Indirli R, Ferrante E et al (2020) Clinically Nonfunctioning Pituit Incidentalomas: Characteristics Nat History Neuroendocrinol 110(7\u20138):595\u2013603","journal-title":"Clinically Nonfunctioning Pituit Incidentalomas: Characteristics Nat History Neuroendocrinol"},{"issue":"1","key":"1716_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ejendo\/lvad070","volume":"189","author":"R Hamblin","year":"2023","unstructured":"Hamblin R, Fountas A, Lithgow K, Loughrey PB, Bonanos E, Shinwari SK et al (2023) Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. Eur J Endocrinol 189(1):87\u201395","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1716_CR17","first-page":"010502","volume":"35","author":"A Dib","year":"2025","unstructured":"Dib A, Leleu D, Lemaire S, Duvillard L, M\u00e9n\u00e9gaut L, Denimal D (2025) Is the stability of ACTH in whole blood a genuine concern during the preanalytical phase? A systematic review. Biochem Med (Zagreb) 35(1):010502","journal-title":"Biochem Med (Zagreb)"},{"key":"1716_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clinbiochem.2020.04.004","volume":"81","author":"V Nandakumar","year":"2020","unstructured":"Nandakumar V, Paul Theobald J, Algeciras-Schimnich A (2020) Evaluation of plasma ACTH stability using the Roche Elecsys immunoassay. Clin Biochem 81:59\u201362","journal-title":"Clin Biochem"},{"issue":"2","key":"1716_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3171\/2018.4.JNS172148","volume":"131","author":"JH Kim","year":"2019","unstructured":"Kim JH, Dho YS, Kim YH, Lee JH, Lee JH, Hong AR et al (2019) Developing an optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas. J Neurosurg 131(2):500\u2013506","journal-title":"J Neurosurg"},{"key":"1716_CR20","doi-asserted-by":"publisher","first-page":"1613239","DOI":"10.3389\/fendo.2025.1613239","volume":"16","author":"ME Iftimie","year":"2025","unstructured":"Iftimie ME, Burcea IF, Dobre R, Pigni S, Prodam F, Poian\u0103 C (2025) Long-term behaviour of non-functioning pituitary microadenomas: experience from a tertiary care centre in Romania. Front Endocrinol (Lausanne) 16:1613239","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1716_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"PU Freda","year":"2011","unstructured":"Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894\u2013904","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1716_CR22","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jacr.2018.03.037","volume":"15","author":"JK Hoang","year":"2018","unstructured":"Hoang JK, Hoffman AR, Gonz\u00e1lez RG, Wintermark M, Glenn BJ, Pandharipande PV et al (2018) Management of Incidental Pituitary Findings on CT, MRI, and (18)F-Fluorodeoxyglucose PET: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol 15(7):966\u2013972","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"1716_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11102-018-0924-0","volume":"22","author":"LB Nachtigall","year":"2019","unstructured":"Nachtigall LB, Karavitaki N, Kiseljak-Vassiliades K, Ghalib L, Fukuoka H, Syro LV et al (2019) Physicians\u2019 awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a Pituitary Society survey. Pituitary 22(1):37\u201345","journal-title":"Pituitary"},{"issue":"2","key":"1716_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11102-018-0928-9","volume":"22","author":"JF Bonneville","year":"2019","unstructured":"Bonneville JF (2019) A plea for the T2W MR sequence for pituitary imaging. Pituitary 22(2):195\u2013197","journal-title":"Pituitary"},{"issue":"5","key":"1716_CR25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ejendo\/lvaf091","volume":"192","author":"A Fountas","year":"2025","unstructured":"Fountas A, Lithgow K, Loughrey PB, Bonanos E, Shinwari SK, Mitchell K et al (2025) Conservatively managed non-functioning pituitary macroadenomas-cohort study from the UK Non-functioning Pituitary Adenoma Consortium. Eur J Endocrinol 192(5):680\u2013690","journal-title":"Eur J Endocrinol"},{"key":"1716_CR26","doi-asserted-by":"publisher","first-page":"108920","DOI":"10.1016\/j.clineuro.2025.108920","volume":"254","author":"YJ Kim","year":"2025","unstructured":"Kim YJ, Moon KS, Park SJ, Jung TY, Kim IY, Jung S (2025) Natural history and predictors of growth in conservatively managed non-functioning pituitary macroadenomas: A volumetric study of 232 tumors. Clin Neurol Neurosurg 254:108920","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"1716_CR27","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1210\/jc.2005-2552","volume":"91","author":"OM Dekkers","year":"2006","unstructured":"Dekkers OM, Pereira AM, Roelfsema F, Voormolen JH, Neelis KJ, Schroijen MA et al (2006) Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91(5):1796\u20131801","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1716_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13014-022-02133-z","volume":"17","author":"T Charleux","year":"2022","unstructured":"Charleux T, Vendrely V, Huchet A, Trouette R, Ferri\u00e8re A, Tabarin A et al (2022) Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery? Radiat Oncol 17(1):165","journal-title":"Radiat Oncol"},{"issue":"4","key":"1716_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000430815","volume":"102","author":"G Carosi","year":"2015","unstructured":"Carosi G, Malchiodi E, Ferrante E, Sala E, Verrua E, Profka E et al (2015) Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas: Focus on the Prevalence of Isolated Central Hypoadrenalism. Neuroendocrinology 102(4):267\u2013273","journal-title":"Neuroendocrinology"},{"key":"1716_CR30","doi-asserted-by":"crossref","unstructured":"Constantinescu SM, Duprez T, Fomekong E, Raftopoulos C, Alexopoulou O, Maiter D (2023) Natural history and surgical outcome of incidentally discovered clinically nonfunctioning pituitary macroadenomas. Endocr Connect 12(12)","DOI":"10.1530\/EC-23-0224"},{"issue":"7","key":"1716_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1055\/a-2096-1340","volume":"55","author":"SD Rikvold","year":"2023","unstructured":"Rikvold SD, Pedersen MB, Andreassen M, Krogh J (2023) Natural History of Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-Analysis. Horm Metab Res 55(7):443\u2013451","journal-title":"Horm Metab Res"},{"issue":"4","key":"1716_CR32","doi-asserted-by":"publisher","first-page":"bvaa021","DOI":"10.1210\/jendso\/bvaa021","volume":"4","author":"PU Freda","year":"2020","unstructured":"Freda PU, Bruce JN, Khandji AG, Jin Z, Hickman RA, Frey E et al (2020) Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study. J Endocr Soc 4(4):bvaa021","journal-title":"J Endocr Soc"},{"issue":"1","key":"1716_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-16-0041","volume":"175","author":"SA Imran","year":"2016","unstructured":"Imran SA, Yip CE, Papneja N, Aldahmani K, Mohammad S, Imran F et al (2016) Analysis and natural history of pituitary incidentalomas. Eur J Endocrinol 175(1):1\u20139","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1716_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11102-022-01289-x","volume":"26","author":"L Caulley","year":"2023","unstructured":"Caulley L, Whelan J, Khoury M, Mavedatnia D, Sahlollbey N, Amrani L et al (2023) Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review. Pituitary 26(1):73\u201393","journal-title":"Pituitary"},{"issue":"4","key":"1716_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/cen.70080","volume":"104","author":"M Solak","year":"2026","unstructured":"Solak M, Kraljevi\u0107 I, Brekalo R, Peterkovi\u0107 V, Polovina T, Bala\u0161ko A et al (2026) Rethinking the Long-Term Follow-Up Strategy for Non-Functioning Pituitary Neuroendocrine Tumours in a Real-World Setting. Clin Endocrinol (Oxf) 104(4):343\u2013351","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1716_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11102-023-01335-2","volume":"26","author":"KY Fong","year":"2023","unstructured":"Fong KY, Lim MJR, Fu S, Low CE, Chan YH, Deepak DS et al (2023) Postsurgical outcomes of nonfunctioning pituitary adenomas: a patient-level meta-analysis. Pituitary 26(4):461\u2013473","journal-title":"Pituitary"},{"issue":"1","key":"1716_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11102-007-0007-0","volume":"10","author":"OM Dekkers","year":"2007","unstructured":"Dekkers OM, de Keizer RJ, Roelfsema F, Vd Klaauw AA, Honkoop PJ, van Dulken H et al (2007) Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma. Pituitary 10(1):61\u201365","journal-title":"Pituitary"},{"issue":"6","key":"1716_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0002-9394(00)00539-0","volume":"130","author":"JB Kerrison","year":"2000","unstructured":"Kerrison JB, Lynn MJ, Baer CA, Newman SA, Biousse V, Newman NJ (2000) Stages of improvement in visual fields after pituitary tumor resection. Am J Ophthalmol 130(6):813\u2013820","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1716_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ecl.2020.05.010","volume":"49","author":"S Frara","year":"2020","unstructured":"Frara S, Rodriguez-Carnero G, Formenti AM, Martinez-Olmos MA, Giustina A, Casanueva FF (2020) Pituitary Tumors Centers of Excellence. Endocrinol Metab Clin North Am 49(3):553\u2013564","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"1716_CR40","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1210\/jc.2003-030461","volume":"88","author":"FG Barker 2nd","year":"2003","unstructured":"Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88(10):4709\u20134719","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1716_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/neuonc\/noz225","volume":"22","author":"R Kotecha","year":"2020","unstructured":"Kotecha R, Sahgal A, Rubens M, De Salles A, Fariselli L, Pollock BE et al (2020) Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion. Neuro Oncol 22(3):318\u2013332","journal-title":"Neuro Oncol"},{"issue":"6","key":"1716_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","volume":"38","author":"M Brada","year":"1993","unstructured":"Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38(6):571\u2013578","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01716-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:42:20Z","timestamp":1788457340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01716-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01716-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nil.","order":3,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"117"}}